Actinium Pharmaceuticals (ATNM) EBT Margin (2018 - 2026)
Actinium Pharmaceuticals (ATNM) posted EBT Margin of 79.72% for Q2 2026.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) EBT Margin (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Actinium Pharmaceuticals was 31.40%; for FY2025, it was -37652.22%.
- Annual EBT Margin shows a five-year change of -25071.89 percentage points (FY2020 to FY2025).
- In prior years, Actinium Pharmaceuticals' EBT Margin was -60269.14% in FY2023 (-56958.07 pp), -3311.07% in FY2022 (-1128.90 pp) and -2182.17% in FY2021 (+10398.17 pp).
- The Q2 2026 figure stands as the highest quarterly EBT Margin in data going back to Q1 2018.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q3 2023, with a gain of 20540.58 percentage points; the weakest was Q4 2021, with a drop of 23291.30 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 79.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.72% |
| Mar 31, 2026 | -1,449.34% |
| Sep 30, 2025 | -5,701.11% |
| Jun 30, 2025 | -1,100.48% |
| Mar 31, 2025 | -2,276.86% |
| Sep 30, 2024 | -1,119.85% |
| Jun 30, 2024 | -1,066.01% |
| Mar 31, 2024 | -935.28% |
| Dec 31, 2023 | -915.01% |
| Sep 30, 2023 | -1,234.98% |
| Jun 30, 2023 | -3,293.06% |
| Mar 31, 2023 | -2,117.73% |
| Sep 30, 2022 | -21,775.56% |
| Jun 30, 2022 | -17,444.44% |
| Mar 31, 2022 | -549.36% |
| Dec 31, 2021 | -34,991.30% |
| Sep 30, 2021 | -2,776.39% |
| Jun 30, 2021 | -1,907.89% |
| Mar 31, 2021 | -863.67% |
| Dec 31, 2020 | -11,700.00% |
API Access
Actinium Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();